Press Release

DemeRx appoints ibogaine pioneer Juan Sanchez-Ramos to scientific advisory board

DemeRx Adds Ibogaine Researcher Juan Sanchez-Ramos to Scientific Advisory Board

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

DemeRx Strengthens Leadership Team With Appointment of Biopharmaceutical Executive Michael Snitkovsky as Chief Operations Officer

DemeRx Appoints Michael Snitkovsky as COO

Commissioner’s National Priority Voucher (CNPV) Pilot Program

DemeRx Announces Successful Completion of Multiple Ascending Dose Clinical Trial of DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)

In Waves and War: Healing Trauma Through the Science of Neuroplasticity

DemeRx Awarded $1.7 Million National Institutes of Health Grant

DemeRx Appoints Biopharma Industry Veteran Vic Pirotsky to Board of Directors